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Abstract
Keratins are cytoskeletal intermediate filament proteins that are increasingly being recognised for their diverse cellular
functions. Here we report the consequences of germ line inactivation of Keratin 76 (Krt76) in mice. Homozygous disruption
of this epidermally expressed gene causes neonatal skin flaking, hyperpigmentation, inflammation, impaired wound
healing, and death prior to 12 weeks of age. We show that this phenotype is associated with functionally defective tight
junctions that are characterised by mislocalization of the integral protein CLDN1. We further demonstrate that KRT76
interacts with CLDN1 and propose that this interaction is necessary to correctly position CLDN1 in tight junctions. The
mislocalization of CLDN1 has been associated in various dermopathies, including the inflammatory disease, psoriasis. These
observations establish a previously unknown connection between the intermediate filament cytoskeleton network and
tight junctions and showcase Krt76 null mice as a possible model to study aberrant tight junction driven skin diseases.
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Introduction
The epidermis provides a stable and selectively permeable
barrier essential to terrestrial life. Together with microfilaments
and microtubules, intermediate filaments (IFs) make up the major
components of the epidermal cytoskeleton. Keratins are the largest
subgroup of the IF proteins and comprise the major structural
proteins in epithelial cells [1]. Keratins are composed of a central,
filament forming, alpha-helical rod domain of ,310 amino acids
that is flanked by non-helical head and tail domains [1,2,3,4,5].
They act as a flexible scaffold enabling cells to resist physical stress.
Consequently, defects in IFs can lead to cell fragility and are linked
to a wide array of genodermatoses and cancers [5,6]. The classical
view that keratins simply provide a structural scaffold has been
challenged by recent studies demonstrating their increasingly
specialised and diverse functions [7]. These include protection
from apoptosis [8,9] and injury [10], regulation of epithelial
polarity [11,12] and influence on cell size and protein transla-
tion[10,13,14,15].
The functional integration of cytoskeletal elements and cellular
junctions is critical for the establishment and maintenance of the
epidermal barrier. Tight junctions (TJ) form a seal between cells
which make up the layers of the epidermis [16]. This barrier is
selectively permeable, allowing passage of small molecules, but
restricting water loss, and allowing for antigen sampling by
immune cells [16,17,18]. TJs are composed of scaffolding and
adhesion molecules including claudins, junctional adhesion
molecules and occludins. Defective tight junction organization
has been linked to compromised barrier function [17] and the
development of various dermopathies including psoriasis [19,20].
The TJs are thought to interact with the IF network by binding of
a number of integral or associated TJ proteins that complex to to
F-actin [21] but their associations, if any, with the keratin IF
network are unclear.
In this report we have studied the effects of Krt76 disruption in
mice and demonstrate that the KRT76 protein is essential for
postnatal survival beyond ,3 months of age. Loss of KRT76 leads
to the acquisition and infection of skin wounds which fail to properly
resolve over time. This phenotype correlates with observations
showing that the gene is up-regulated during normal wound healing
and is required for this process. At a mechanistic level we show that
loss of KRT76 is associated with defective tight junction function
through the mislocalization of Claudin1 (CLDN1), an integral TJ
component which we show binds to KRT76. These findings identify
a critical new relationship between the IF network and TJs which
we propose is essential for epidermal homeostasis.
Results
Loss of Krt76 causes gross epidermal defects and results
in lethality
As part of the Wellcome Trust Sanger Institute (WTSI) Mouse
Genetics Programme [22], we screened the skin of the mutant
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mouse strains generated. This skin screen is discussed in an
accompanying article in this issue of PLoS Genetics [23]. From
this screen we identified significant cutaneous defects in mice
homozygous for the gene trap ‘‘knockout first’’ [24] allele of
Keratin 76 (Krt76tm1a(KOMP)Wtsi hereafter Krt76tm1a) (Figure 1A)
[23]. These animals have a splice acceptor-LacZ reporter
integrated upstream of floxed exon 2 that allows gene expression
to be traced whilst disrupting gene function. Quality control of this
mutant allele and correct genome positioning has been confirmed
by long range PCR (http://www.sanger.ac.uk/mouseportal/
search?query=krt76). Krt76 expression has previously been report-
ed in the palatal and gingival epithelium [25]. By utilising the
integrated LacZ reporter in our Krt76tm1a/+ model we confirmed
expression at these locations but also detected previously unreported
expression in the vagina and the eyelid (Figure 1B).
Krt76tm1a mice were then further back-crossed onto a C57BL/6
genetic background and bred back to homozygosity to determine
the full consequences of Krt76 disruption. Krt76tm1a/tm1a neonates
exhibit flaky skin (Figure 1C, arrow-insert), although these defects
diminish somewhat with the emergence of hair follicles. After
weaning, mutant mice are distinguished by their unkempt, dull
coats and smaller body size (Figure 1D, E) and by scaling of skin of
the tail (Figure 1F) [26]. Krt76tm1a/tm1a mice also show abnormal
paw pad hyperpigmentation (Figure 1G) which corresponds with
Krt76 expression as reported by LacZ, which is observed
throughout the stratified epidermal layers and in the exocrine
glands (Figure 1H, H9, I).
Haematoxylin and Eosin (H&E) staining of wild type (WT) and
Krt76tm1a/tm1a paw pads revealed an overall epidermal thickening,
with reduced granular layer compaction and an increased
cornified layer (Figure 1J, J9). Pigment was also observed in the
dermis (Figure 1J9 see arrowhead). To further explore KRT76
expression, we performed immuno-staining on paw pad skin using
antibodies raised against human KRT76 epitopes that are
predicted to be disrupted in tm1a animals. Specific KRT76
expression was highest in the granular cell layer where it
overlapped with Filaggrin (FLG) in serial sections (Figure 1K).
This site of expression correlates with b-galactosidase activity
detected via the integrated reporter gene (Figure 1I). Importantly
granular layer staining was absent from Krt76tm1a/tm1a animals
(Figure 1L) and Western blots from epidermal extracts of the mid-
dorsum and face epidermis confirmed that the tm1a allele results
in complete loss of KRT76 protein (Figure 1M). We did detect low
levels of immuno-staining in basal keratinocytes in Krt76tm1a/tm1a
skin which was slightly reduced compared to wild type mice when
imaging was performed using the same confocal settings. Given
the unequivocal Western results, one interpretation is that this
basal signal is a combination of non-specific cross reactivity and
low levels of bona fide expression at this location. However, we
cannot exclude the possibility that this change instead relates to
alterations in expression of the cross-reacting species that might
occur as a consequence of loss of KRT76. Further studies, perhaps
using different antibodies, would be required to confirm this.
To examine a developmental role for the gene we profiled protein
expression during embryonic and postnatal skin development,
showing increasing levels of protein associated with the differenti-
ation of the skin during late embryonic development, followed by a
subsequent reduction in expression levels after birth (Figure 1N).
Importantly though, low levels of KRT76 were still detectable in the
spinous and granular cell layers in intact adult dorsal skin
(Figure 1N). As expected, KRT76 protein was absent in
Krt76 tm1a/tm1a animals by both immunofluorescence (compare
Figure 1N with Figure 1N9) and qRT-PCR (Figure 1O), further
validating this allele as a bona fide knockout model. This profile also
suggests KRT76 may have a role in the later steps of keratinocyte
differentiation, an observation which correlates with the flaky skin
phenotypes observed in Krt76tm1a/tm1a neonates (Figure 1C).
Krt76 is associated with barrier maturation wound
healing
As they age, Krt76tm1a/tm1a mice develop spontaneous wounds
that fail to heal, especially on the dorsal skin around sites of active
grooming (Figure 2A, see arrow head). Histological examination
showed no obvious phenotypic change in young Krt76tm1a/tm1a
mice prior to significant wound acquisition (which we refer to as
the ‘‘early’’ phenotype), but large scabs, immune dermal infiltrates,
extreme IFE thickening (Figure 2B) and hyperpigmentation in the
dermis and epidermis develop over time (arrrowheads, Figure 2B).
Phospho-histone H3 staining demonstrated a hyperproliferative
response in these mice (Figure 2C, D). The morbidity associated
with loss of KRT76 is such that animals rarely survive beyond 12
weeks of age. To assess whether cutaneous bacterial infection of
these spontaneous wounds may exacerbate morbidity, we treated
Krt76tm1a/tm1a mice with a broad spectrum antibiotic (Baytril) and
observed a considerable improvement in lifespan (median survival
= 70 days versus 32 (p,0.04)) (Figure 2E).
The wounding phenotypes associated with Krt76tm1a/tm1a mice
led us to examine whether KRT76 was directly involved in the
healing of induced wounds. As a first step in addressing this
question we sampled dorsal skin from Krt76tm1a/+ and WT mice 1,
3, 5, 7, and 10 days after wounding by punch biopsy to examine
gene expression. Immunofluorescence staining for KRT76 showed
an up-regulation of KRT76 protein in the healing wound 5 days
after injury (Figure 2F). This was confirmed by LacZ staining in
Krt76tm1a/+ wound sections (Figure 2G). Expression profiling by
qRT-PCR in WT mice confirmed Krt76 mRNA upregulation in
response to wounding, with a profile slightly delayed in
comparison to the ‘‘classical’’ wounding keratins Krt6b and
Krt16 (Figure 2H). Similar punch biopsy experiments in the
dorsal epidermis in Krt76tm1a/tm1a mice resulted in a significant
impairment in wound closure at day 3 and day 5, correlating with
the peak of Krt76 expression in the wound (Figure 2I). These
observations indicate that that KRT76 is normally upregulated in
response to skin damage and is required to facilitate wound
healing during the latter phases of this process.
Biochemical analysis of Krt76 disrupted skin
We next examined whether the skin of Krt76tm1a/tm1a mice
underwent a normal program of differentiation. The basal keratin
marker, Keratin 14 (KRT14) and the hair follicle expression of
Author Summary
The generation of knockout mice is a central approach to
studying gene function. We have examined the conse-
quences of the germ line inactivation of Keratin 76 in mice
and in doing so we reveal a previously undescribed
mechanism by which keratin intermediate filaments
regulate cellular interactions and tissue homeostasis. Our
study supports an emerging body of evidence which
challenges the classical view of the keratin intermediate
filaments as simple structural proteins, highlighting Krt76
as a gene whose function is indispensable for barrier
function and skin wound repair as a result of its novel
interaction with tight junction complexes. This study
identifies a previously unknown and critical link between
intermediate filaments and tight junctions where interme-
diate filament dysfunction influences skin disease.
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Figure 1. Krt76 gene trap disruption causes gross epidermal defects. (A) Schematic showing Krt76 gene trap (knock-out first) targeting
construct. (B) Whole mount LacZ staining of Krt76tm1a/+ reporter mice, shows Krt76 expression in the dorsal and ventral snout and palate, eyelid, and
vagina. (C) Mice homozygous for Krt76 gene trap disruption (Krt76tm1a/tm1a) exhibit flaky skin following birth (see arrow-insert). Adult Krt76tm1a/tm1a
mice exhibit a scruffy coat and smaller body weight (n = 3 males, age 9 weeks, ***p,0.004) (D, E), as well as tail scaling (F). Krt76tm1a/tm1a mice exhibit
paw pad hyperpigmentation (G), concurring with regions of LacZ reporter expression (H). LacZ expression within paw pads is detected in exocrine
glands (H9) and suprabasal epidermal layers (I). (J, J9) Haemotoxylin and Eosin (H&E) staining of paw pads from WT (J) and Krt76tm1a/tm1a (J9) mice.
Yellow arrowheads indicate abnormal dermal pigmentation. (K, L) Immunofluorescence analysis with indicated antibodies in wild type and
Krt76tm1a/tm1a mouse paw pad. Samples are counter stained with nuclear dye DAPI (4’,6-diamidino-2-phenylindole). Coloured brackets indicate
approximate distribution of FLG and KRT76 expression around the granular layer. (M) Western blot analysis of WT and Krt76tm1a/tm1a dorsal skin and
face skin extracts. (N) Immunofluorescence analysis with anti-KRT76 and anti-K14 antibodies in wild type mouse dorsal skin at E14.5, E18.5, P1 and
adult time points and adult Krt76tm1a/tm1a dorsal skin (N9). Asterisks indicate non-specific basal layer staining. (O) Krt76 mRNA qRT-PCR analysis of p3
dorsal skin relative to Gapdh. Scale bars represent 50 mm.
doi:10.1371/journal.pgen.1004706.g001
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Keratin 6 (KRT6) [27] were normal in ‘‘early’’ phenotype
Krt76tm1a/tm1a dorsal skin but both expanded in the interfollicular
epidermis (IFE) of ‘‘late’’ phenotype Krt76tm1a/tm1a indicative of a
wounding response (Figure 3A). Likewise, the psoriasis and
wounding associated factor, Fatty acid binding protein 5 (FABP5)
[28,29], showed normal weak suprabasal IFE expression in WT
and ‘‘early’’ phenotype Krt76tm1a/tm1a mice which increased
dramatically when wounds developed in ‘‘late’’ phenotype
Krt76tm1a/tm1a mice (Figure 3B). Keratin 10 (KRT10), a marker
of the stratum spinosum, and Filaggrin (FLG), a marker of the
stratum granulosum, were again normal in early phenotype
Krt76tm1a/tm1a dorsal skin but expanded upon wounding in late
Figure 2. Krt76 is required for normal wound healing. (A) Krt76tm1a/tm1a gene trap mice show spontaneous wounds around the eyes and
shoulders (sites of grooming). (B) H&E staining of dorsal skin from adult WT, early and late phenotype Krt76tm1a/tm1a mice. Yellow arrowhead indicates
abnormal pigmentation in the dermis and epidermis. (C) Immunofluorescence phospho-histone H3 (pHH3) analysis of wild type and Krt76tm1a/tm1a
mouse dorsal skin shows (D) increased proliferation/pHH3 positive cells (p= 0.005). E) Krt76tm1a/tm1a mice die progressively from ,2 weeks after birth
with no animals surviving beyond 12 weeks of age. Treatment with Baytril reduces morbidity and mortality. (F) Immunofluorescence analysis with
anti-KRT76 and anti-K14 antibodies in non-wounded and wounded wild type dorsal skin after 5 days. (G) LacZ staining of the wounded skin from
Krt76tm1a/+ reporter mice at 7 days post wounding. (H) Krt76, Krt6b and Krt16mRNA qRT-PCR analysis of wounded skin relative to Gapdh, over 10 days.
(I) Quantification of wound closure in wild type and Krt76tm1a/tm1a mice over 10 days. *p,0.05, Error bars are S.E.M. Scale bars represent 50 mm.
doi:10.1371/journal.pgen.1004706.g002
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phenotype mice (Figure 3C, D). We also surveyed lipid profiles of
the cornified envelope with Nile Red, demonstrating that the
deposition of extracellular lipid lamellae were unaffected in mutant
animals (Figure 3E). The terminal products of epidermal differ-
entiation, the corneocytes, also appeared to form normally, albeit
with a small but significant reduction in surface area which we
propose derives from hypercellularity in the epidermis (Figure 3F).
While the overall differentiation of keratinocytes in late phenotype
Krt76tm1a/tm1a dorsal skin was mostly normal, the hyperplasia,
immune infiltrate and IFE expression of KRT6 and FABP5, were
reminiscent of the hyperproliferative skin disorder, psoriasis
[30,31,32]. We also observed enlargement of sebaceous glands
shown histologically in Figure 2B and further indicated by
sebocyte markers, FABP5 and FASN [33,34] (Figure 3B, G).
Hyperpigmentation was also analysed using an MELAN-A (MEL-
A) antibody which revealed dermal melanocytes were abnormally
increased in density in the dermis and pigment increased in late
phenotype Krt76tm1a/tm1a epidermis (Figure 3H). Their location
concurred with the increased incidence of pigment detected in
H&E sections [35] (Fig. 2B, upper arrowhead).
The progressive deterioration of the skin in these mice led us to
examine whether the barrier function and integrity of the skin was
compromised as a result of loss of KRT76 function. Dorsal skin from
3 week old mice (without overt wounding) were subjected to toluidine
blue dye exclusion tests and no dye penetrance was observed
indicating an intact outside to inside barrier (Figure 3I). Unlike other
models of intermediate filament dysfunction, we observed no
evidence of cell fragility and intraepidermal cell breakages by
histology. This was confirmed using tape stripping assays, which
showed no increased susceptibility to dye uptake (Figure S1A) and
similar yields of corneocytes in tape stripping assays (Figure S1B).
Histological and biochemical analysis of conditional Krt76
knockout skin
To further confirm that the phenotypes we observed were
representative of a null allele, and to confirm the phenotype we
observed was driven by gene deletion in the epidermis and not in
another organ, we generated a conditional KRT76 allele by
crossing these mice with a flippase expressing line to remove the
LacZ and NeoR cassettes; thereby generating a Krt76tm1c allele
(Figure 4A). Mice homozygous for Krt76tm1c were functionally
and phenotypically wild type. This allele was then manipulated to
achieve gene deletion by crossing to Cre-driver strains (Figure 4A
and Protocol S1). Global gene inactivation using CMV-Cre
recapitulated the gene trap phenotype, resulting in early postnatal
lethality. Temporally controlled Krt76 deletion specifically in the
epidermis was achieved by topical application of 4-hydroxytamox-
ifen (4OHT) to the dorsal skin of 8 weeks old Krt76tm1c/tm1c mice
carrying a K14-CreER transgene. These animals (Krt76tm1d/tm1d)
showed regions of IFE hyperplasia and wounding after 3 weeks of
treatment (Figure 4B) which was consistent with KRT76 deletion
in these areas (Figure 4C, see granular layer absence indicated by
arrowhead). As with Krt76tm1a/tm1a mice, hyperproliferation was
increased in conditional knockouts (Figure 4D) as well as up-
regulation of KRT14, KRT6 and FABP5 IFE expression
(Figure 4E, F). Both KRT10 and FLG cell layers appeared to
differentiate in normal sequence and showed wound related
expansion (Figure 4G, H). The sebaceous glands were again
enlarged, as shown by both FABP5 and FASN staining (Figure 4F,
I) and like genetrap Krt76tm1a/tm1a mice, an increase in Melanin-A
reactivity was seen (Figure 4J). Taken together these experiments
confirm that the phenotypes we observe in these mice are due to
epidermal specific knockout of KRT76.
Krt76 mutant mice show barrier function defects
Hyper-proliferation, induction of wounding keratins, unresolved
wounds, and follicular dysmorphology are phenotypes associated
with a loss of barrier function. Neonatal barrier function in dorsal
skin was examined using a transepidermal water loss (TEWL) assay
and identified a significant defect in the cutaneous barrier in
Krt76tm1a/tm1a pups compared to their control littermates (Fig-
ure 5A). Importantly, this dorsal skin defect (at P3) was apparent
before obvious skin wound lesions develop. As our previous
phenotypic characterisation indicated this barrier function break-
down was unlikely to be linked to overt defects in cell stability,
epidermal stratification, lipid deposition or terminal differentiation
we examined tight junctions (TJ). Loss of TJ functionality can result
in a compromised epidermal barrier independent of defects in lipid
deposition or keratinocyte differentiation [16,17]. Furthermore,
alterations in TJ proteins are an early event in psoriasis [20], a
disease with phenotypes that parallel some of those evident in
Krt76tm1a/tm1a and Krt76tm1d/tm1d mice. To investigate TJ integrity
we subcutaneously injected P3 mouse paw pads with membrane
impermeable Sulfo-NHS-Biotin and tracked its diffusion using
streptavidin immunohistochemistry. In WT epidermis, the diffusion
of this high molecular weight compound was restricted before the
interface of the granular and cornified layers, defined by FLG
expression (Figure 5B), but in Krt76tm1a/tm1a littermates the tracer
was detected within the cornified layer (Figure 5B, see arrowhead).
Co-staining with a cell surface marker (CLDN1) showed regions of
distal dye exclusion in wild type animals (Figure 5C, see region
defined by arrowheads), which were absent in mutant mice, further
indicating that TJ function in these animals was disrupted
(Figure 5C). The ultrastructure of TJ’s in P3 paw pad was grossly
normal (e.g. kissing points) and their number and position were
comparable to their WT and heterozygote littermates (Figure S1C).
Desmosomes also appeared normal (Figure S1C).
Krt76 stabilises Claudin1 at tight junctions
In assessing the diffusion of the biotin tracer in paw pad skin we
noted that CLDN1 exhibited broader margins at the cell periphery
and acquired a partial (albeit weak) nuclear localization (Figure 5C).
This altered distribution was also observed and quantified in
samples stained with CLDN1, DAPI and E-cadherin (Figure 5D, E,
F), which confirmed the inward shift and partial nuclear localisa-
tion. While CLDN1 is typically a cytoplasmic protein, nuclear
redistribution of CLDN1 has been previously reported [36]. Dorsal
skin from young animals taken prior to the development of
wounding phenotypes also exhibits mislocalisation of membranous
CLDN1 (Figure 5G) and this was further exacerbated when wounds
formed (Figure 5H), although CLDN1 in the nucleus was not
evident at this anatomical site (Figure 5I). Mislocalisation was also
confirmed inKrt76tm1d/tm1d samples (Figure 5J, K). No difference in
total CLDN1 protein levels were observed in mutant skin relative to
ECAD (Figure 5I) nor was there a difference in Cldn1 mRNA
expression (Figure S1D). This data collectively suggests KRT76 is
Figure 3. Biochemical analysis of Krt76 disrupted skin. (A-E, G–H) Immunofluorescence (or dye) analysis of wild type, early and late phenotype
Krt76tm1a/tm1a dorsal skin as indicated. (F) Isolated corneocytes from wild type and Krt76tm1a/tm1a mouse dorsal skin exhibit a modest reduction in
surface area (F9) (***p = 0.0004). I) Dye exclusion assay revealed no defects in outside to inside barrier function in Krt76tm1a/tm1a mouse dorsal skin.
Error bars = S.E.M. Scale bars represent 50 mm.
doi:10.1371/journal.pgen.1004706.g003
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Figure 4. Histological and biochemical analysis of conditional Krt76 knockout skin. (A) Exon structure and domain prediction of mouse
Krt76 gene. Blue box represents insertion of b-galactosidase (b-gal/LacZ) cassette in the Krt76tm1a reporter allele. Green circles and red triangles
indicate frt and loxP sites. Validation of the mutant alleles was achieved using PCR amplification (see Protocol S1). (B) H&E staining of dorsal skin from
4OHT-treated control and Krt76tm1d/tm1d mice. (C–J) Immunofluorescence analysis of 4OHT-treated control and Krt76tm1d/tm1d mouse dorsal skin as
indicated. Yellow arrowhead indicates absence of granular layer KRT76 staining. Asterisks indicate non-specific staining. Scale bars represent 50 mm.
doi:10.1371/journal.pgen.1004706.g004
Keratin 76 Is Required for Skin Barrier Function
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Figure 5. Krt76 mutant mice show barrier function defects and KRT76 stabilises Claudin1 at tight junctions. (A) Transepidermal water loss
assay on P3 dorsal skin from wild type and Krt76tm1a/tm1a mice. (B) P3 paw pad skin was dermally injected with a biotin tracer and diffusion through the
epidermis assessed, with Filaggrin (FLG) and DAPI co-staining for tissue orientation. Yellow arrowhead shows diffusion in suprabasal keratinocytes into
cornified layer. (C) Biotin tracer was assessed alongside TJ component, Claudin1 (CLDN1). Tracer exclusion indicated by flanking yellow arrowheads. (D)
Immunofluorescence analysis of CLDN1 and Ecadherin (ECAD) distribution in wild type and Krt76tm1a/tm1a mouse dorsal skin. (E) Image quantification at
the cellular surface shows an inward shift and a decrease in intensity of CLDN1 not observed with ECAD. (F) Further quantification by image analysis of
CLDN1 co-localisation at the cell surface with ECAD or DAPI in the nucleus. (G, H) Immunofluorescence analysis of CLDN1 localization in dorsal skin of
wild-type and Krt76tm1a/tm1a mice in early phenotype and biopsy wounded adult dorsal skin of wild-type and Krt76tm1a/tm1a mice. (I) Dorsal skin
fractionation assay showing localisation of different proteins to different fraction; relative lcoalisation of CLDN1 are indicated in (I9). (J, K)
Immunofluorescence analysis of CLDN1 localization in adult dorsal skin and paw pads of 4OHT-treated conditional Krt76 knock-out mice and control
sibling. Note paw pad phenotype from grooming transfer of tamoxifen. *p,0.05, **p,0.01. Error bars = S.E.M. Scale bars represent 50 mm.
doi:10.1371/journal.pgen.1004706.g005
Keratin 76 Is Required for Skin Barrier Function
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required to correctly position CLDN1. Analysis of other TJ
components ZO-1 and OCLN confirmed that the mislocalisation
was specific to CLDN1 (Figure S2 and S3). In conclusion, our
observations using several different experimental approaches
indicate that KRT76 is required for normal TJ composition and
in particular, the correct membrane localization of CLDN1.
KRT76 interacts with Claudin1
Given that KRT76 is required for normal CLDN1 localization
we next assessed a possible physical association between the
proteins. Although KRT76 antibodies proved unsuitable for co-
immunoprecipitation experiments, we were able to express the tail
domain of the protein and conjugate this to nickel magnetic beads.
Paw pad lysates were then applied to the beads and interacting
proteins eluted. Using this approach we were able to identify a
specific interaction between the tail domain of KRT76 and
endogenous CLDN1 (23 kDa) and a second higher molecular
weight species (,50 kDa) which may represent previously
reported CLDN1 dimers [37,38]. No such interactions were
observed with the HIS-tag control protein (Figure 6A). These
bands were absent from samples containing bound HIS-tail
domain protein not incubated with paw skin extracts. This assay
thereby shows that KRT76 can physically complex with CLDN1
although we cannot determine if this interaction is direct or
indirect. The available reagents meant that performing the reverse
reaction (pull-down on CLDN1) was impossible in the mouse, so
we instead employed the human A549 adenocarcinomic alveolar
basal epithelial cell line which we determined to endogenously
express both proteins (Figure 6B). Using these cells we were able to
co-immunoprecipitate KRT76 with CLDN1. Furthermore, ZO-1
(another TJ component) did not form part of this interaction
complex, indicating the interaction between KRT76 and CLDN1
is specific amongst TJ components (Figure 6B). CLDN1 and
KRT76 were also observed to co-localise in punctate structures
within the cytoplasm of A549 cells (Figure 6C, see arrowheads).
These interaction and co-localization assays confirm a physical
complex between CLDN1 and KRT76 which we propose is
important for mediating the barrier dysfunction and wound
healing phenotypes of the KRT76 knockout mouse.
Discussion
The keratins are classically regarded as structural proteins
whose role is to form the fabric of the cytoskeleton and to stabilise
Figure 6. KRT76 interacts with Claudin1. (A) HIS-tagged KRT76 tail domain and HIS-tag alone where produced in E.coli, purified and immobilised
on nickel-resin. Resin was then incubated with mouse paw pad lysates and the specific pull-down of CLDN1 with the KRT76- tail domain and not HIS-
tag was shown by anti-Claudin1 WB. (B) Soluble extracts were prepared from A549 cells and anti-CLDN1 or non-immune IgG antibody
immunoprecipitated. IP and lysate/input samples were then blotted for ZO-1, CLDN1 and KRT76. (C) A549 cells co-express CLDN1 and KRT76 and
these colocalise in cytoplasmic punctate structures -see arrowheads.
doi:10.1371/journal.pgen.1004706.g006
Keratin 76 Is Required for Skin Barrier Function
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epithelial cells. However, this somewhat simplistic view has
increasingly been challenged by the description of their specialised
and dynamic functions in a number of cellular and developmental
contexts. The keratins are the most diverse class of intermediate
filament proteins and in many cases their functions are poorly
defined. In this study we describe the characterisation of KRT76,
one of the least understood of the protein family, delineating its
essential role in the maintenance of the integrity of the skin. Under
resting conditions, Krt76 is expressed at its highest levels in the
paw, oral epithelium and vagina, localising to the granular layer. It
is also expressed in the dorsal epithelium, particularly during the
late stages of embryonic development. Wounding induces Krt76
expression, although the profile of this induction is distinct from
other wounding keratins like Krt6 and Krt16.
To examine the functional relevance of this expression and its
role in epidermal homeostasis we inactivated the gene in mice
globally and in a skin specific manner. Loss of Krt76 results in the
rapid appearance of extensive non-healing wounds (especially at
sites of active grooming), and the subsequent infection of these
lesions contributes significantly to morbidity and mortality in the
mice. Unlike other knockout models of structural keratins we failed
to observe cytolysis and/or blistering in the skin. Instead we
observed a relatively unperturbed program of keratinocyte
differentiation although this gives way to a phenotype of
hyperproliferation as the phenotype of the animals worsens. What
triggers this change remains to be determined, however the
frequency of wounds around active grooming sites suggests that
KRT76 deletion may impair the ability of the skin to recover from
physical insults normally experienced in the life of the mouse. This
theory is supported by the demonstration that induced wounds in
the skin of these mice, administered prior to the accumulation of
significant cutaneous damage, failed to heal normally.
As well as the progressive wounding phenotype observed in
these mice, we also noted cellular changes which were consistent
with defects in the barrier function of the epidermis. This was
confirmed using trans-epidermal water loss assays in neonatal
animals. We were unable to establish a role for defective
keratinocyte stability or termination in driving this defect, nor
was lipid transport affected in the mice to any appreciable level.
Instead, we observed the specific mislocalisation of the TJ
component CLDN1, even in newborn mice and in animals
without overt or severe cutaneous defects. Indeed previous reports
have shown that even significant hyperproliferation induced by
two step carcinogenesis treatments is unable to elicit similar
changes [39]. Although TJs appeared normal at an ultra-structural
level, their reduced capacity to limit the movement of molecules
between differentiating keratinocytes in our mice suggests that they
were functioning abnormally. Importantly mislocalisation was not
observed for other structural elements of the TJ. It is therefore
notable that the phenotype of the Krt76 KO mice is strikingly
similar to animals carrying homozygous mutations in Cldn1 [17].
In both cases, barrier function defects are detectable by biotin
tracer and TEWL assays (but not by dye exclusion), and both have
apparently normal formation of TJ structures as assessed by EM.
Overall, the phenotypes of Krt76 null mice are somewhat milder
than their CLDN1 counterparts, suggesting that despite loss of
KRT76, some CLDN1 can still contribute to partial TJ function.
By studying both skin extracts and cell lines endogenously
expressing both CLDN1 and KRT76 we were able to demonstrate
a physical association between these proteins, mediated by the tail
domain of the latter. At present we do not know whether this
interaction is direct, or whether the proteins exist in a larger
complex. In either case, the loss of KRT76 is clearly required for
normal tight junction function and for CLDN1 localisation.
Although links between the tight junction and the cytoskeleton
have been described for actin, this is the first report detailing an
interaction with the keratin intermediate filaments.
In summary, we believe that the KRT76 protein represents a
new and essential protein required for maintaining epidermal
integrity. Its expression during fetal development and during
wound healing suggests it is required to establish and/or stabilise
the development of TJs in differentiating keratinocytes, specifically
through mediating the correct localisation off CLDN1 to these
structures. Deletion of the protein leads to defects in TJ function
that are at least in part associated with the development of
progressively worsening wounds. Whether this severe later
phenotype, which ultimately leads to the death of the animals,
reflects a separate, non-TJ, role for the protein in wound repair is
unclear. Mislocalization of CLDN1 is a feature of a number of
cutaneous diseases such as psoriasis [40], and in a number of
cancers [36,41,42]. KRT76 depletion has also been linked with
human oral carcinomas and premaligant epidermal changes [43].
It will therefore be interesting to determine the extent to which this
new cytoskeletal-TJ interface between CLDN1 and KRT76
interaction plays a role in the development or progression of
these diseases.
Materials and Methods
Ethics statement
Animal models were maintained under the auspices of ethics
applications to Monash University and subject to the conditions of
the Australian Bureau of Animal Welfare.
Transgenic mice
Krt76tm1a/tm1a mice were generated in the Mouse Genetics
Programme at the Wellcome Trust Sanger Institute [24]. Animals
were bred and maintained on a mixed background of C57BL/
6JTyrcBrd; C57BL/6N. The Krt76tm1a/tm1a characterisation data
presented is available at www.mousephenotype.org. Targeting
vector information is available at http://www.mousephenotype.
org/martsearch_ikmc_project/martsearch/ikmc_project/38047.
Flip recombinase (Flipper) mice [44], K14-CreER mice [45] and
CMV-Cre mice [46] have been described previously. 1.5 mg of 4-
hydrotamoxifen (H6278, Sigma-Aldrich) was applied to a shaved
region of lower back skin in 100 ml of acetone every second day for
21 days before mice were harvested for analysis.
Genotyping transgenic mice
The PCR conditions were set for amplification of small PCR
fragments only. Details of primer sequences, reaction composition
and cycling profile are provided in Protocol S1.
Histological preparation and staining
Staining for LacZ expression was performed as previously
described [47] on frozen sections and counterstained with Nile
Red. Immunofluorescence experiments were performed after
citrate based antigen retrieval. Primary antibodies were ZO-1
(Invitrogen cat# 339100), Occludin (BD Transduction cat#
611090), Claudin-1 (ABCAM cat# ab15098), cytokeratin14 -
LLOO2 (ABCAM cat # ab7800), keratin10 (Covance PRB-
159P), keratin6 (Covance cat # PRB-169P), Ecadherin (Life
Technologies, 13-1900), phospho-histone H3 (Cell Signalling,
#9708), PCNA (Santa Cruz Biotechnology sc-9857), CLDN1
(Santa Cruz Biotechnology, sc-81796), Keratin 76 (Sigma-Aldrich
HPA019696) and Keratin 76 (Sigma-Aldrich HPA019656),
Filaggrin (FLG- Covance PRB-417P), FASN (Santa Cruz
Biotechnology, sc-48357), and Melan-A (MEL-A, Santa Cruz
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Biotechnology, sc-20032). All secondary antibodies were Alexa-
Fluor conjugated (Invitrogen).
Imaging and analysis
Sections were imaged using Lecia SP5 5 Channel, Olympus
FV500 confocal microscopes or Aperio slide scanners. Bright field
images of wound healing experiments were taken with Olympus
dotslide brightfield microscope. Images for CLE assays were
acquired with Olympus CKX41 and exported to FIJI software
[48] for cell analysis.
Wound healing experiments
Mice (age-matched males; 6 weeks) were isofluorane-anaesthe-
tized and 2 full-thickness excisional wounds were made with a
5 mm biopsy punch (Livingstone International). Wound tissue was
harvested with an 8 mm biopsy punch.
qRT-PCR
One mg of DNase (Ambion) treated RNA was used for cDNA
synthesis (SuperScriptVILO). Multiplex quantitative PCR was
performed using Taqman probes for Gapdh (VIC-primer limited
labelled, cat# 4448484) and Krt76 (FAM labelled, Cat#4351372)
with TaqMan Fast Advanced Master Mix Protocol (PN 4444605B).
Gene specific primers were designed and used in conjunction with
SYBR Green PCR Master Mix (Applied Biosystems) for the
detection and quantification of Claudin1 (59-ATTTCAGGTCTG-
GCGACATT-39 fwd, 59-ACACCTCCCAGAAGGCAGAG-3-
rev) , Krt6b (59-CAGACCCCAGATACCCTGGC-39 fwd, 59-GA-
GCAGAGATGGCATCATGTGAGCAACAGG-39 rev) , Krt16
(59- AACAGCCTAGAAGAGACCAAAGGC-39 fwd, 59-GGTA-
GGGGAGACAGATGGGGAATGCGC-39 rev) mRNA as com-
pared to Gapdh (59- CTGCACCACCAACTGCTTAG-39 fwd,59-
GTCTTCTGGGTGGCAGTGAT-39 rev).
Protein fractionation
All fractionation experiments were performed on dorsal epider-
mis of P3 animals. Pups were euthanized (Pentobarbital) and skin
was removed as previously described [49]. Skins were floated on
2.3 U/mL Dispase (Life Technologies) in PBS overnight at 4uC.
The epidermis was separated from the dermis and protein
fractionated using a Qproteome Cell Compartment Kit (Qiagen).
Western blots for E-cadherin (Life Technologies) and total Histone
H3 (Cell Signaling) were performed on the nuclear and membrane
fractions. Image Quant software was used to calculate densitometry
and quantify protein levels. Claudin-1 levels in the membrane
fraction were normalized to E-cadherin for each sample.
Biotin tracer assays
TJ permeability assays were undertaken as previously described
[17,50]. Briefly, a solution of 10 mg/ml EZ-Link Sulfo-NHS-LC-
Biotin (Pierce) in PBS containing 1 mM CaCl2 was injected into
the paw pads of P3 pups. Paw pads were incubated at room
temperature for 30 minutes prior to frozen sectioning and IHC
with conjugated Streptavidin Alexafluor 594 (Life Technologies,
S-11227).
Ultrastructural analysis
Tissue was fixed in Karnovsky’s fixative (2% paraformaldehyde,
2.5% glutaraldehyde in 0.1 M Cacodylate buffer) for 2 hours.
Then washed in 3610 min changes of 0.1 M Cacodylate buffer.
Post-fixation was with 2% osmium tetroxide in 0.1 M Cacodylate
buffer followed by dehydration through a graded series of alcohols,
two acetone rinses and embedding in Spurrs resin. 80 nm sections
were cut with a diamond knife (Diatome, Switzerland) on an
Ultracut-S ultramicrotome (Leica, Mannheim, Germany) and
contrasted with uranyl acetate and lead citrate. Images were
captured with a Megaview II cooled CCD camera (Soft Imaging
Solutions, Olympus, Australia) in a JEOL 1011 transmission
electron microscope.
HIS-tag Pull-down from Mammalian Lysates
Recombinant HIS-tagged proteins were produced by IPTG
induction (0.4 mM) of T7 Express lysY/Iq Competent E.coli (New
England Biolabs C3013I) transformed with HIS-tag expressing
control vector, pET-30a+ (Novagen) or HIS-tagged KRT76
domains in pDEST17 gateway backbone (Life Technologies),
grown for 6–8 hours at 37uC in low salt LB, supplemented with
100 mg/ml ampicillin or 50 mg/mL kanamycin (as required).
Recombinant protein was purified using 0.1 ml per 1 ml of culture
of PopCulture lysis reagent (Novagen), 1 ml per mL of culture of
40 U/ml of Lysonase bioprocessing reagent (Novagen), protease
inhibitors (Sigma P8849), and His-Mag beads (Novagen) accord-
ing to manufacturer’s protocols. Bound recombinant HIS and
HIS-KRT76 protein were washed and stored at 4uC as a 1:2 resin
slurry in Tris-saline pH 7.4 containing protease inhibitors. Paw
pad skin of adult was collected in RIPA lysis buffer and incubated
with HIS or HIS-KRT76 overnight at 4uC. HisMag bead-bound
HIS and HIS-KRT76 + lysates were then washed four times in
Tris-saline pH 7.4 including 1% Triton X-100 and immuno-
blotted for mCLDN1 (Santa Cruz Biotechnology, SC-81796) and
the HIS tag (Sigma-Aldrich, clone HIS-1).
A549 analysis and CO-IP
A549 cells (ATCC CCL-185) were cultured in low-glucose
DMEM including 10% FCS, Penicillin Streptomycin and L-
glutamine. For CO-IP, cells at confluence were scraped and lysed
in 1% Triton X-100 in 1xTBS with Roche complete protease
inhibitor tablet, extracted for 2 hrs at 4uC then supernatant
collected. The supernatant was applied to binding columns
prepared using the Pierce Crosslink IP Kit and CO-IP performed
as per manufacturers protocol. Bound fractions were washed 3
times in lysis buffer before elution and standard WB analysis. For
Immunofluorescence, 26105 cells were seeded on Collagen type 1
coated glass coverslips in 6 well plate format and processed as
previously described [51].
Dye exclusion
E18.5 embryos or 3 week old dorsal skin were collected and
transferred through a Methanol gradient with emersion for
1 minute each: 25% methanol in water, 50% methanol in water,
75% methanol in water, 100% methanol, 75% methanol in water,
50% methanol in water, 25%methanol in water and equilibrated in
PBS. All reagents were chilled. Tissue was then exposed to 0.1%
Toluidine Blue solution in water for 2 minutes and destained in
1xPBS pH7.4. For tape stripping, clipped dorsal skins were first tape
stripped twelve times with adhesive tape before tissue collection.
Cornified envelope assay
Analysis of the size of corneocytes in the cornified lipid envelope
(CLE) assay was performed as previously published [52].
Statistical analysis
Statistical analysis was performed using unpaired students test,
values of p,0.05 were deemed significant. A minimum of 3 mice
were analysed per condition unless otherwise stated. In graphs,
error bars represent Standard Error of the Mean (S.E.M).
Keratin 76 Is Required for Skin Barrier Function
PLOS Genetics | www.plosgenetics.org 11 October 2014 | Volume 10 | Issue 10 | e1004706
Supporting Information
Figure S1 Tape stripping and TJ ultrastructure. (A) Dye
exclusion assay with and without tape stripping revealed no
fragility in Krt76tm1a/tm1a mouse dorsal skin. (B) Quantification of
corneocyte yield in tape stripping assay (Figure 3F). (C) Electron
micrographs of TJ ultrastructure in wild type and Krt76tm1a/tm1a
mice. TJ = tight junctions, D= desmosome. (D) Cldn1 mRNA
qRT-PCR analysis of p3 paw pad skin relative to Gapdh (n = 3), ns
= not significant. Error bars represent S.E.M.
(TIF)
Figure S2 ZO-1 at tight junctions. (A) Immunofluorescence
analysis of ZO-1 demonstrates co-expression with KRT76 in
suprabasal cells of the paw pad. (B, D) No obvious changes were
detected in ZO-1 localization in paw pads of Krt76tm1a/tm1a mice.
(C, D) Immunofluorescence analysis of ZO-1 in wild type and
wounded Krt76tm1a/tm1a mouse dorsal skin showed only a modest
change in intensity. (E, F) In contrast to CLDN1, ZO-1 changes in
dorsal skin correlate with wounding and not Krt76 disruption.
Scale bars represent 50 mm.
(TIF)
Figure S3 Occludin at tight junctions. (A, B) Immunofluores-
cence analysis of Occludin (OCLN) demonstrates an increase in
intensity are cell margins in the paw pads of Krt76tm1a/tm1a mice.
(C) Immunofluorescence analysis of OCLN in conditional Krt76
mouse dorsal skin shows OCLN is not expressed in dorsal skin nor
wounded dorsal skin, but is detected in the hair follicle. Scale bars
represent 50 mm.
(TIF)
Protocol S1 This file details the primer sequences and
amplification conditions employed to genotype the different
Krt76 alleles employed during this study.
(XLSX)
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